Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Publication Of Implementation Of Breast Health Guidelines For Developing Countries
http://www.medicalnewstoday.com/articles/124563.php
A special supplement of the Oct. 15 journal <i>Cancer</i> for the first time details guidelines for low- and middle-income countries to implement breast cancer programs to detect and treat the most common disease among women worldwide.
Scientist Aims To Improve Chemotherapy Breast Cancer Treatments, University Of Wolverhampton
http://www.medicalnewstoday.com/articles/124505.php
A University of Wolverhampton scientist has received a grant worth £15,000 from leading research charity Breast Cancer Campaign to investigate improvements to chemotherapy treatment. Around 40 per cent of cancers are resistant to chemotherapy and some patients will see their breast cancer return.
Cancer Experts: Everyday Changes Protect Against Breast Cancer
http://www.medicalnewstoday.com/articles/124483.php
October is National Breast Cancer Awareness Month and the American Institute for Cancer Research (AICR) is dedicated to providing free information to help women learn about their risks and take action to lower them.
----------------------------------------------
** CANCER / ONCOLOGY News **
Oral Cancer Drug REVLIMID(R) Receives Marketing Authorization From Health Canada For Treatment Of Multiple Myeloma
http://www.medicalnewstoday.com/articles/124564.php
Celgene International Sarl (NASDAQ: CELG) announced that its oral cancer drug REVLIMID (lenalidomide) has received marketing authorization approval from Health Canada for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.
Battling Cancer, One Cell At A Time
http://www.medicalnewstoday.com/articles/124561.php
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level.
Alternatives For Radiation Of Low-Grade Brain Tumors Found By Pediatric Study
http://www.medicalnewstoday.com/articles/124546.php
A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can be effective in treating pediatric patients with unresectable or progressive low-grade glioma.
Endoscopic Therapy May Offer An Alternative To Surgery
http://www.medicalnewstoday.com/articles/124540.php
Endoscopic therapy is emerging as an alternative to surgery in patients with esophageal cancer given the low likelihood of spread to the lymph nodes. New research presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando evaluated the long-term efficacy of endoscopic mucosal resection, or EMR, in the treatment of patients with early stage esophageal cancer or Barrett's esophagus.
Novel Way Cells Are Disrupted In Cancer Traced By Cold Spring Harbor Laboratory Scientists
http://www.medicalnewstoday.com/articles/124538.php
A splicing factor targets known cancer-related proteinsA research team at Cold Spring Harbor Laboratory (CSHL) is clarifying a previously unappreciated way that cellular processes are disrupted in cancer.
New Therapeutic Treatment Approach Improves Survival In Esophageal Cancer Patients
http://www.medicalnewstoday.com/articles/124533.php
A study released at the 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found that a new therapeutic treatment, when delivered endoscopically and used in combination with chemotherapy and radiation therapy, improved survival rates in patients with locally advanced esophageal cancer.
Patent Awarded To LSUHSC For Compound Inhibiting Cancer And Other Diseases
http://www.medicalnewstoday.com/articles/124513.php
Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC Professor of Physiology, have been awarded a US Patent for a compound to inhibit the formation of blood vessels critical to the growth of cancerous tumors and diseases like diabetic retinopathy, obesity, and psoriasis.
Scientist Aims To Improve Chemotherapy Breast Cancer Treatments, University Of Wolverhampton
http://www.medicalnewstoday.com/articles/124505.php
A University of Wolverhampton scientist has received a grant worth £15,000 from leading research charity Breast Cancer Campaign to investigate improvements to chemotherapy treatment. Around 40 per cent of cancers are resistant to chemotherapy and some patients will see their breast cancer return.
Improved Drug Discovery Using Nanoscopic Screening Process
http://www.medicalnewstoday.com/articles/124504.php
Researchers at Wake Forest University are using nanotechnology to search for new cancer-fighting drugs through a process that could be up to 10,000 times faster than current methods.The "Lab-on-Bead" process will screen millions of chemicals simultaneously using tiny plastic beads so small that 1,000 of them would fit across a human hair.
Treating Unresectable Liver Metastases From Melanoma - Investigator Presents On Delcath Systems Phase III Trial Experience
http://www.medicalnewstoday.com/articles/124502.php
Delcath Systems, Inc. (NASDAQ: DCTH) reported that the Adjunct Principal Investigator for its Phase III clinical trial, James Pingpank, Jr., MD, discussed interim results from its randomized study of high-dose melphalan, delivered via the Company's Percutaneous Hepatic Perfusion (PHP) system, in patients with inoperable liver metastases from melanoma.
Lance Armstrong To Receive American Association Of Cancer Institutes' Public Service And Advocacy Award
http://www.medicalnewstoday.com/articles/124498.php
The Lance Armstrong Foundation (LAF) is proud to announce that its founder and chairman, Lance Armstrong, is the 2008 recipient of the American Association of Cancer Institutes' (AACI) Public Service and Advocacy Award.
Frontiers In Cancer Prevention Research Meeting To Be Hosted By AACR
http://www.medicalnewstoday.com/articles/124496.php
<b>Premier international meeting highlights breakthrough research to defeat cancer before it starts</b>What:To stop cancer before it has a chance to take root and spread, scientists are increasingly turning their attention to new discoveries in cancer prevention.
Cancer Experts: Everyday Changes Protect Against Breast Cancer
http://www.medicalnewstoday.com/articles/124483.php
October is National Breast Cancer Awareness Month and the American Institute for Cancer Research (AICR) is dedicated to providing free information to help women learn about their risks and take action to lower them.
U Of T Researchers Reveal Epstein-Barr Virus Protein Contributes To Cancer
http://www.medicalnewstoday.com/articles/124475.php
Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development.
Oral Anticancer Drug CP-4126 Enters Clinical Phase I Study
http://www.medicalnewstoday.com/articles/124429.php
Clavis Pharma ASA (OSE: CLAVIS) announced today that its first oral anticancer drug, called Oral CP-4126, has entered Clinical Phase I. The purpose of the study is to evaluate the drug's safety and the uptake of the active metabolite in the body.
Revealing Metastatic Movements In 3-D
http://www.medicalnewstoday.com/articles/124428.php
Caswell et al.report in the <i>Journal of Cell Biology</i> how the altered behavior of integrins can prompt metastatic movement in tumor cells.On 2D surfaces, cells may migrate randomly, or be strongly unidirectional.
Cancer Stories: How Telling The Tale Impacts The Illness, November 6-8, Indiana University School Of Medicine
http://www.medicalnewstoday.com/articles/124418.php
Cancer patients, nurses, doctors, advocates and scholars will gather Nov. 6-8 on the Indiana University School of Medicine campus to explore how stories about cancer have affected perceptions about the illness.
Landmark Discovery Of 'Engine' That Drives Cell Movement
http://www.medicalnewstoday.com/articles/124414.php
How a cell assembles its internal machinery required for cell movement has been revealed for the first time. The discovery, by scientists in Singapore, is published in the October 2008 issue of <i>Cell</i>.
Researchers Explore Issues Related To Multiple Myeloma Treatment
http://www.medicalnewstoday.com/articles/124400.php
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Less Tobacco Exposure Required In Women To Increase Colon Cancer Risk
http://www.medicalnewstoday.com/articles/124545.php
While smoking poses a health threat to both men and women, women require less tobacco exposure than men to have a significant increased risk for colorectal cancer, according to new research presented at the 73rd Annual ACG Scientific Meeting in Orlando.
The Importance Of Bowel Prep And Effectiveness Of Colonoscopy Highlighted By New Studies
http://www.medicalnewstoday.com/articles/124536.php
New research presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando emphasizes the importance of adequate bowel preparation prior to colonoscopy, and highlights the remarkable effectiveness of colonoscopy in detecting and removing pre-cancerous polyps, particularly tiny, flat, potentially pre-cancerous growths in the colon known as "sessile serrated adenomas.
Detection Of Polyps During Colonoscopy Improved By New Screening Technologies
http://www.medicalnewstoday.com/articles/124535.php
Two studies presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando highlight new technologies with the potential to improve the detection of colorectal polyps and flat lesions during colonoscopy.
Colorectal Cancer Risk Increased By Metabolic Syndrome
http://www.medicalnewstoday.com/articles/124529.php
In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.
Task Force Finds Several Methods Equally Effective For Colorectal Cancer Screening
http://www.medicalnewstoday.com/articles/124410.php
In a change from its previous recommendation, the U.S. Preventive Services Task Force now recommends that adults age 50 to 75 be screened for colorectal cancer using annual high-sensitivity fecal occult blood testing, sigmoidoscopy every five years with fecal occult testing between sigmoidoscopic exams, or colonoscopy every 10 years.
New Study Examines Effectiveness Of Colorectal Cancer Screening Tests
http://www.medicalnewstoday.com/articles/124399.php
New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently negative screenings up to the age of 75.
Large Study Shows Stool DNA Testing For Colorectal Cancer Has Potential, But Challenges Remain
http://www.medicalnewstoday.com/articles/124398.php
The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of <I>Annals of Internal Medicine</I>.
----------------------------------------------
** LUNG CANCER News **
Red Wine May Lower Lung Cancer Risk
http://www.medicalnewstoday.com/articles/124463.php
Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of <a href="http://cebp.aacrjournals.org/" target="_blank" rel="nofollow"><i>Cancer Epidemiology, Biomarkers and Prevention,</i></a> a journal of the American Association for Cancer Research.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Oral Cancer Drug REVLIMID(R) Receives Marketing Authorization From Health Canada For Treatment Of Multiple Myeloma
http://www.medicalnewstoday.com/articles/124564.php
Celgene International Sarl (NASDAQ: CELG) announced that its oral cancer drug REVLIMID (lenalidomide) has received marketing authorization approval from Health Canada for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.
New Stanford Diagnostic Test For Rare Leukemia Seems To Provide Faster Results, Study Finds
http://www.medicalnewstoday.com/articles/124527.php
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco.
Phase III Study Showed Rituxan Combined With Chemotherapy Improved Progression-Free Survival In Patients With Relapsed Chronic Lymphocytic Leukemia
http://www.medicalnewstoday.com/articles/124525.php
Genentech, Inc. (NYSE:DNA) and Biogen Idec (Nasdaq:BIIB) announced that a global Phase III study of Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide chemotherapy met its primary endpoint of improving progression-free survival (PFS), as assessed by investigators, in patients with previously treated CD20-positive chronic lymphocytic leukemia (CLL) compared to chemotherapy alone.
DKMS, Whole Foods And The Deerfield Community Band Together To Help Save Chicago Father In Need Of A Bone Marrow Transplant
http://www.medicalnewstoday.com/articles/124495.php
Come to the Bone Marrow Donor Drive and Become a Life-Saver DKMS, Whole Foods and the Deerfield community are joining forces to help save the life of Jon Simon, a Deerfield resident of 30 years, whose only chance of survival is a bone marrow transplant.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
http://www.medicalnewstoday.com/articles/124422.php
Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC™ that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US.
Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
http://www.medicalnewstoday.com/articles/124389.php
Dendreon Corporation (Nasdaq: DNDN) announced that it has completed the planned interim analysis of the Phase 3, randomized, double-blind, placebo-controlled IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical trial designed to assess the safety and efficacy of the investigational active cellular immunotherapy PROVENGE(R) (sipuleucel-T) in men with metastatic androgen-independent prostate cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
1 comment:
The Asbestos Mesothelioma Guide assists patients who suffer from the lung cancer mesothelioma, also known as asbestos cancer, and a resource for family, friends and loved ones in learning about mesothelioma and other asbestos related injuries.
We have compiled and consolidated the latest information on mesothelioma asbestos cancer, mesothelioma symptoms, mesothelioma causes, mesothelioma diagnosis, mesothelioma types including pleural, malignant, peritoneal and mesothelioma treatment.
------------
albertjames
Viral Marketing
Post a Comment